Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually.

Slides:



Advertisements
Similar presentations
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.
Advertisements

Trial profile Fox K et al. Lancet 2008;372:
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
חזק בהגנה לבבית Valsartan in Heart Failure
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
1 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately.
INTRODUCTION Polypharmacy and Distinctive Demographics of Congestive Heart Failure Patients Seenu Abraham 1, Peter Vayalil 1, Sagar Patel 1, Tim Quinn.
The ONTARGET Trial Reference The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:15.
Readmission and Chronic illness that could benefit from end of life discussions.
The Burden of Diabetes 1. Prevalence of Diabetes and Prediabetes in the United States 2 1. CDC. National diabetes fact sheet, 2008.
Quality of Care and Outcomes in Patients with Diabetes Hospitalized with Ischemic Stroke Findings From Get With The Guidelines-Stroke Reeves MJ; Vaidya.
MUSCULOSKELETAL DISEASES National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Heart Failure Disease Management Within the North Florida/South Georgia VHS Richard S. Schofield MD Lynnette Boyer ARNP Cardiology Section North Florida/South.
DO DIETITIANS HAVE A ROLE? Renee Wing, Sodexo Dietetic Intern Orange Park Medical Center January 22, 2013.
PREVENTING READMISSIONS OF CONGESTIVE HEART FAILURE PATIENTS Daidreanna Whiteman Senior Project Columbus State University Summer 2014.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
Cardiovascular Disease in Women Module I: Epidemiology.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Estimation of overweight-attributable deaths Katherine M. Flegal, Ph.D. Centers for Disease Control and Prevention National Center for Health Statistics.
Chronic Care Management Hypertension Results: Represents Health Disparities Collaborative for Hypertension Overall CAP Results.
“The African American Prostate Cancer Crisis in Numbers”
S. HUNT Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
Morbidity and Mortality in Contemporary CAD Patients With Hypertension Treated With Either a Verapamil/Trandolapril or Beta-Blocker/Diuretic Strategy (INVEST):
Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Eskisehir Osmangazi University, Cardiology Department Eskisehir, Turkey Prof. Dr. Yüksel ÇAVUŞOĞLU, MD, FESC Board Member of the Working Group of Heart.
OVERALL SURVIVAL Adapted from Scandinavian Simvastatin Survival Study Group Lancet 1994;344: % of patients alive Simvastatin (n=2221)
Sebastian Schneeweiss, M.D., Sc.D. Instructor in Medicine and Epidemiology Director for Policy Studies Division of Pharmacoepidemiology and Pharmacoeconomics.
Wayne Rosamond, et al. Circulation 2007;115; e69-e171.
The Costs of Chronic Disease
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
Can Nurses Assist Older CHF Patients With Self-Care? Sallie A. Alvarez NGR 5800 American Heart Association.
Gender & Non-Gender Specific Cancer. Quick Facts On average, 386 Canadian men will be diagnosed with prostate cancer every week. On average, 407 Canadian.
GERIATRIC EDUCATION SERIES Presented in partnership by Funded in part by a grant from the EJC Foundation.
Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
2007 Hypertension as a Public Health Risk January, 2007.
Journal Club Mallory McClester, PGY-4 August 16, 2013.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.
Acute Renal Failure in Aneurysmal Subarachnoid Hemorrhage: Nationwide Analysis of Hospitalizations in the United States Kavelin Rumalla 1, Adithi Y. Reddy.
Funded in part by a grant from the EJC Foundation Presented in partnership by GERIATRIC EDUCATION SERIES.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: U.S. Hospital Use of Echocardiography: Insights.
The Burden of Diabetes.
The Burden of Diabetes.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
Ageing with ideal cardiovascular risk factors
Valsartan in Acute Myocardial Infarction Trial Investigators
Figure 4 BMI and mortality in patients with heart failure
A. Heart failure: A challenge to the healthcare delivery system
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
PARADIGM-HF Trial design: Participants with NYHA class II-IV and LVEF ≤40% were randomized to LCZ mg twice daily (n = 4,187) vs. enalapril 10 mg.
ATMOSPHERE Trial design: Patients with symptomatic heart failure were randomized in a 1:1:1 fashion to either aliskiren 300 mg once daily, enalapril 5.
$13.8 Billion Hip Fractures $8.68 billion (63.1%)
TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Nat. Rev. Cardiol. doi: /nrcardio
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Baseline Characteristics of the Patients – Part I
Baseline Characteristics by hs-CRP
Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Presentation transcript:

Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually 1Over 250,000 deaths annually 1 Over 3 times the number of breast and prostate cancer deaths combined 2Over 3 times the number of breast and prostate cancer deaths combined 2 Over 850,000 hospitalizations annually 1Over 850,000 hospitalizations annually 1 Incidence is growing 1Incidence is growing 1 1. American Heart Association; 1997 Heart and Stroke Statistical Update 2. American Cancer Society; Estimated New Cancer Cases and Deaths by Sex for All Site, United States, 1996

Prevalence by Gender and Age of CHF (NHANES Survey) Schocken DD, et al., J Am Coll Cardiol, 1992;20:301

Incidence of Hospitalizations for Heart Failure Third highest cause in all patientsThird highest cause in all patients Leading cause of hospitalizations in patients over 65Leading cause of hospitalizations in patients over 65 Approximately 35% of diagnosed heart failure patients are hospitalized per yearApproximately 35% of diagnosed heart failure patients are hospitalized per year National Center for Health statistics. Series 13, No. 108, 1989.

Readmission Rates Within 90 Days in Elderly Patients Vinson JM, et al., J Am Geriatr Soc, 1990;38:1290 First Admission

Readmissions for Elderly Patients For heart failure patients (>  70 years), multiple hospitalizations within six months are common. The 3-month readmission rate can be as high as 47%For heart failure patients (>  70 years), multiple hospitalizations within six months are common. The 3-month readmission rate can be as high as 47% Many readmissions for heart failure may be preventableMany readmissions for heart failure may be preventable Vinson JM, et al., J Am Geriatr Soc, 1990;38:1290

Calcium Channel Blockers Multicenter Diltiazem Post- Infarction Trial (MDPIT)* EF <40% *Subgroup analysis of patients with EF < 40% The Multicenter Diltiazem Post Infarction Trial Study Group N Engl J Med., 1988;319:385-92